Your email has been successfully added to our mailing list.

×
0.00147819660014766 0.0140428677014042 0.0073909830007391 -0.0162601626016261 -0.00517368810051741 0.024390243902439 -3.69549150037324E-05 0.0273466371027345
Stock impact report

Elevai Bioscience up on portfolio expansion with new filings for muscle loss treatment in obese patients [Seeking Alpha]

Elevai Labs, Inc. (ELAB) 
Company Research Source: Seeking Alpha
These patent applications cover both standalone and combination therapies using EL-22 alongside GLP-1 receptor agonists, marking a significant advancement in obesity treatment. Source: Press Release More on Elevai Labs Elevai Labs Inc. (ELAB) National Hair Loss Aesthetics Slide Presentation Next Generation Skin & Scalp Rejuvenation Slideshow Elevai Labs announces pricing of $8 million public offering INmune and Elevai Labs amend licensing deal Financial information for Elevai Labs Recommended For You Comments More Trending News Show less Read more
Impact Snapshot
Event Time:
ELAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ELAB alerts

from News Quantified
Opt-in for
ELAB alerts

from News Quantified